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Abstract
Background: Organophosphate pesticides are widely used on food crops grown in the EU. While they have been
banned from indoor use in the US for a decade due to adverse health effects, they are still the most prevalent
pesticides in the EU, with Chlorpyrifos (CPF) being the most commonly applied. It has been suggested CPF affects
neurodevelopment even at levels below toxicity guidelines. Younger individuals may be more susceptible than
adults due to biological factors and exposure settings.
Methods: A literature review was undertaken to assess the evidence for CPF contributing to neurodevelopmental
disorders in infants and children. Other literature was consulted in order to formulate a causal chain diagram
showing the origins, uptake, and neurological effects of animal and human exposure to CPF.
The causal chain diagram and a questionnaire were distributed online to scientific experts who had published in
relevant areas of research. They were asked to assess their confidence levels on whether CPF does in fact
contribute to adverse neurodevelopment outcomes and rate their confidence in the scientific evidence. A second
questionnaire queried experts as to which kind of policy action they consider justifiable based on current
knowledge. In a special workshop session at the EuroTox congress in Dresden in 2009 the results of both
questionnaires were further discussed with invited experts, as a basis for a policy brief with main messages for
policy makers and stakeholders.
Results: Most experts who responded to the first questionnaire felt that there was already enough evidence to
support a ban on indoor uses of CPF in the EU. However, most felt additional research is still required in several
areas. The responses from the first questionnaire were used to formulate the second questionnaire addressing the
feasibility of government action. In turn, these expert participants were invited to attend a special session at the
EuroTox congress in Dresden in 2009.
Conclusions: Some of the evidence that CPF contributes to neurodevelopmental disorders is still disputed among
experts, and the overall sense is that further research and public awareness are warranted. There have been
campaigns in North America making the potential exposure concerns known, but such information is not widely
known in the EU. The ability of government action to produce change is strongly felt in some quarters while
others believe better knowledge of consumer use trends would have a greater impact.
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Introduction
Organophosphate (OP) compounds are used worldwide
in agriculture and gardening to control insect pests.
They also have residential and indoor applications for
pest control, especially for cockroaches and termites
[1-6]. OPs act by inhibiting acetylcholinesterase, thus
affecting nerve function in insects, humans and other
animals. Most of the animal and human studies pub-
lished from 2000 onwards refer to the OP chlorpyrifos
(CPF).
There is concern about the safety of CPF in the envir-
onment. While previous studies have shown levels of
CPF that are safe in adult animals, recent evidence indi-
cates young animals and humans may be more sensitive
to CPF toxicity. In young animals, CPF is neurotoxic and
mechanistically interferes with cellular replication and
differentiation. This leads to alterations in the synaptic
transmission in neurons.
OPs are used frequently in Europe for pest control due
to their low price and broad spectrum of activity. In 2003
they accounted for over 59% (4645 tonnes) of insecticide
sales in the EU, with CPF the top selling insecticide
(15.6%, 1226 tonnes) [7]. CPF was also one of the most
widely used OPs in the US for pest control [2], but the
US Environmental Protection Agency (EPA) imposed a
ban on the sale of CPF for residential use in December
2001 [8].
The consideration of whether to ban OPs for domestic
use in Europe is a complex process involving both
health and lifestyle considerations. Moving from scienti-
fic data to policy interpretation is a nontrivial challenge,
because public health risks are scientifically very com-
plex. Scientific assessment of environmental health risks
is faced with large, sometimes irreducible, uncertainties,
knowledge gaps, and imperfect understanding, and may
also have conflicting claims and scientific controversy
[9,10].
The HENVINET project focussed on the four priority
health diseases of the European Environment and Health
Action Plan (EHAP) 2004-2010. These are: asthma and
allergies, cancer, endocrine disrupting effects, and neuro-
developmental disorders. Because CPF is one of the key
environmental pollutants strongly connected in the scien-
tific literature with neurodevelopmental effects, and
because of the North American ban on its domestic use,
HENVINET chose to focus on this pesticide in particular.
In order to better inform policymakers of the scientific
basis of any proposed action, an expert elicitation was
undertaken to identify areas of the research in need of
further examination. This study considers the environ-
mental health effects of CPF exposure in utero and during
childhood and its relationship with neurodevelopment.
The results will be used to form the basis of a decision
support tool that has the aim of preparing policymakers
with the necessary scientific background to address the
concerns surrounding OPs and their applications in the
home.
Scientific Background
Activities involved in the production, storage, transport
and use of CPF may play a role in its release as it is
transferred from the production site to the final user.
Unintentional release through dumping or leakage can
lead to unexpected exposures. The uptake of CPF into
the environment depends on factors such as the
s t r e n g t ha tt h es o u r c ea n dt h ep h y s i c a lf o r m( d r ys o l i d ,
liquid, etc.). The extent of use will also depend on the
time and location. For example, agricultural and garden-
ing use will be influenced by the seasonal growth of
crops and plants, whereas residential use is less likely to
be specifically influenced by the seasons apart from the
climate effects on pest infestation. There may still be a
seasonal influence on child exposure.
Environmental matrix
Dispersion and transformation of CPF from the sources
affects uptake into the environment and may be influ-
enced by transport, climate and the characteristics of the
a r e aw h e r et h e ya r eb e i n ga p p l i e d .T h eu s eo fC P Ff o r
agricultural and gardening purposes will lead to accumu-
lation in soil, water and on food such as vegetables and
fruit as well as atmospheric dispersal [1-5].
However, residential use is considered to be the main
source of contamination in the majority of the population,
alongside contaminated food consumption [5]. This can
lead to accumulation in indoor air, including house dust,
and on surfaces including toys [2,4].
Incorporation of CPF into each environmental matrix
will vary according to concentration and is influenced by
composition (parent compound/environmental metabo-
lite), how the load is spread (concentrated or dispersed),
and the magnitude of the load and the frequency of
application.
Exposure setting
Population behaviour influences interaction between the
environment/exposure setting and the extent of expo-
sure. For CPF, there are three key exposure settings:
occupational, ambient and indoor.
Occupation puts farming and greenhouse workers at
risk from sources used in agriculture and gardening. Simi-
larly, manufacturing workers are also at risk of exposure,
especially if there is an inadvertent leak. The general pub-
lic, especially children, are mainly at risk from ambient
and indoor residential exposure. Several physical processes
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also possible.
Oral exposure can arise particularly from fruit and
vegetables consumed as part of the normal diet, but also
water, milk and derived products [2,4]. Indirect exposure
occurs within the ambient and indoor settings [2-5].
Non-dietary oral exposure (contact with soil and house-
hold objects) is an important exposure route for younger
children due to their behaviour patterns with respect to
play at floor level and on/with other surfaces and toys.
Inhalation of indoor air is another route with house dust
a critical component. Dermal exposure is also possible
through this route [11].
A 1993 review conducted by the US Commission of
Life Sciences examined organophosphate pesticide expo-
sure routes in infants and children. For six pesticides
(chlordane, heptachlor, aldrin, chlorpyrifos, diazinon, and
gamma-BHC), the mean air exposures were consistently
higher than the estimated die t a r ye x p o s u r ef o rt h es a m e
chemicals [12].
One study measured chlorpyrifos concentration follow-
ing flea treatment in a carpeted home. They found CPF
vapours in the infant breathing zone (25 cm above the car-
pet) significantly higher than those measured in the adult
breathing zone. Time-weighted averages for the 24 hours
following application in the infant breathing zone were
41.2 and 66.8 µg/m3 for ventilated and nonventilated
rooms, respectively. This is far higher than the guideline of
10 µg/m3 proposed by the U.S. National Research Coun-
cil’s Committee on Toxicology [13]. Also, air concentra-
tions increased up to 5 to 7 hours after application. This
suggested treated carpets are a source of volatilised chlor-
pyrifos and even with open windows, concentrations
nearest the floor remain high [14].
In assessing risk for infants in chlorpyrifos-treated
homes, Berteau et al. [15] calculated an absorbed dose of
2.68 mg/kg. Fenske et al. [14] found the estimated
absorbed chlorpyrifos dose for infants exceeded the EPA’s
no-observed-effect level of 0.03 mg/kg/day in each case.
The level is based on measured changes in plasma
acetylcholinesterase.
The indoor use of pesticides in public buildings is
another source of exposure. Employees of one school
became ill within hours of entering a building that had
been treated for roaches 3 days earlier and had not been
ventilated. It was 14 days before air levels of the pesticides
decreased to an acceptably safe level and students were
readmitted [16]. An air analysis indicated that the levels
decreased at a much slower rate than indicated by the
manufacturer’sg u i d e l i n e s .
Indoor insecticide sprays and foggers persist on carpets,
floors, and other surfaces in the home. Young children
w e a r i n go n l yd i a p e r sm a ye x p e r i e n c ed e r m a le x p o s u r e
playing on previously sprayed surfaces; children who put
their mouths on objects may ingest the substances. In one
case, pesticide poisoning was suspected when an infant
suffered respiratory arrest and tests showed his red blood
cell cholinesterase levels depressed to 50% of normal
levels. The child’s home had been treated with chlorpyrifos
and the chemical was subsequently found on dish towels,
food preparation surfaces, and the infant’s clothing [17].
Flea control products persist on a pet’sf u ra n dc o u l db e
transferred to children [18].
Exposure during pregnancy is an area of concern given
the high percentage of women using pest control during
pregnancy and the vulnerability of the foetus during devel-
opment. Foetal exposure occurs through transplacental
transfer with the placenta failing to act as a barrier to lipo-
philic OPs [6]. There is limited data concerning the pre-
sence of OP in human breast milk [19], possibly due to
partitioning into the water fraction of breast milk. This
area requires further investigation as it may present an
additional exposure route during the postnatal period [20].
The extent of exposure will be affected by the frequency,
duration and intensity of contact, which can all vary.
There may also be transfer between settings. For example,
a parent who is an agricultural worker may transfer resi-
due to their offspring within the home.
Geographical location of the setting may also play a role
as the dissipation of CPF and its metabolites from food
surfaces has shown a wide range of variation, with shorter
times shown in more tropical climates [21], and longer
times in more temperate ones as well as on foods culti-
vated in winter [22].
Toxicokinetics
The dose of pesticides in organs and tissues is determined
by the pharmacokinetics of CPF: physical absorption, dis-
tribution, metabolism and excretion processes following
uptake. An important element in assessing exposure is the
biological matrix used for sampling. Levels in humans are
determined through biomarkers which may be subject to
interpretation.
For CPF, the most commonly used biomarkers are
found in blood and urine. In blood, exposure is deter-
mined by measurement of plasma butylcholinesterase
(BuChe) activity and erythrocyte acetylcholinesterase
(AChE) activity [23]. Urine measurements detect excre-
tion of metabolites and are more widely used for young
children compared with taking blood samples. CPF is
activated in the liver to CPF-oxon by cytochrome P450-
dependent desulfuration [24].
The most sensitive biomarker for testing foetal expo-
sure is meconium [6,25] as compared with the sensitiv-
ity found in testing cord blood [26]. When tests of
meconium are combined with other markers such as
maternal hair samples, the detection rate is further
increased [27].
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fic marker for exposure [28]. However, organophosphates
are rapidly metabolized in the body and almost entirely
excreted in the urine [3]. Some may be stored in adipose
tissue [28], meaning that parent compound levels in blood
are very low compared with metabolites.
The CPF metabolite 3-5-6 trichloro-2-pyridinol (TCPy)
can be detected in urine [29,30] as can the non-specific
OP dialkyl phosphate (DAP) metabolites formed from
nearly all OP insecticides [5]. For CPF, these DAP metabo-
lites are diethylphosphate (DEP) and diethylthiophosphate
(DETP). However, about 75% of OP pesticides are also
biotransformed to DETP, DEP or other DAPs measured in
the same way and they cannot be distinguished from
environmental degradates [24]. Careful interpretation is
needed when measuring DAPs as they cannot necessarily
be correlated with specific OP insecticides and the meta-
bolites themselves may be ingested [5].
Route of exposure affects absorption and hence body
burden and target organ dose. A case study of CPF and
malathion biomonitoring demonstrated that about 70-93%
o ft h eo r a ld o s eo fC P Fc o u l db er e c o v e r e di nt h eu r i n e
compared to only 1-3% of the dermal dose [28]. Pharma-
cokinetics also influences organ dose and effective dose
through distribution, metabolite production and enzyme
function. OP pesticides can be converted to oxon form
which interacts with cholinesterase. However, the oxon
form can also be enzymatically or spontaneously hydro-
lysed to form a DAP metabolite and an organic metabolite.
Unconverted OP can also be hydrolysed to the organic
group metabolite and DAP metabolites [28]. These meta-
bolites or their conjugates are excreted in urine. There will
also be differences between foetus, newborn, child and
adult metabolisms and how such metabolites are cleared
by kidneys from the system.
Health effects
Age and genetic/acquired predisposition may determine
health effects from the CPF exposure dose. CPF toxicitiy is
due to the inhibition of acetylcholinesterase by the CPF-
oxon, preventing efficient degradation of acetylcholine and
leading to accumulation of transmitter molecules in the
nerve synapse. Elevated synaptic acetylcholine levels result
in persistent receptor stimulation and the alteration of
signalling pathways with functional changes at tissue/
organism level [29].
While some researchers have asserted that CPF does
not affect any biological systems at levels below those
established for extreme cholinesterase inhibition and
acute toxicity [30], numerous animal and in vitro studies
suggest that CPF can act by other mechanisms. They
have also demonstrated that CPF exposure at doses
below the threshold for systemic toxicity and inhibition
of brain cholinesterase exerts disruptive effects on neural
cell development, with respect to DNA synthesis, gene
transcription, cell differentiation, and synaptogenesis
[31]. These effects are particularly enhanced in early
development.
Several rat studies have indicated that CPF targets neu-
rotransmitter systems further to the cholinergic one, as
the monoamines, norepinephrine, dopamine, and seroto-
nin [32]. In addition, glial cells are more sensitive to CPF
than neurons and may be preferentially targeted [33].
Interference with brain maturation is associated with
behavioural disturbances in exposed rodents, including
hyperactivity, learning impairment and alterations in the
social and emotional domain [34-39]. This suggests vul-
nerability during foetal and childhood periods [40]. CPF is
considered moderately toxic and is an EPA class II toxi-
cant i.e. oral dose LD50 is 50-500mg/kg [28].
Juvenile and prenatal susceptibility
Animal studies have demonstrated that juveniles are
more susceptible to OP toxicity than adults [41]. Animal
and in vitro studies show low-dose OP exposure in devel-
opmental periods produces neurochemical and neurobe-
havioural changes [40], even at doses below what would
ordinarily produce detectable changes in brain acetylcho-
linesterase (AChE) [39,42]. Changes such as the mor-
phology of the hippocampus and levels of neural growth
factor [43], excess weight gain [44], and changes in anxi-
ety, maternal behaviour and social responses [45] have
been observed. These suggest interference with hypotha-
lamic neuroendocrine mechanisms. Differences in young
animals are attributed to incomplete metabolic compe-
tence during development [46] and the susceptibility of
the rapidly developing nervous system.
Paraoxonase 1/arylesterase (PON1) is a key OP detoxi-
fying enzyme. Increased sensitivity to OP toxicity in
newborns may be due to reduced PON1 levels, which
are 3- to 4-fold lower than in adults. There is consider-
able PON1 polymorphism and this genetic variability
will affect sensitivity alongside a 13-fold variation in
adult levels [41,47].
Additional noncholinergic mechanisms - such as oxida-
tive stress - may damage the developing brain with expo-
sures occurring below the systemic effects threshold. Thus
nonsymptomatic exposure for pregnant women, infants
and children and could be linked with increased risk for
development of metabolic diseases such as diabetes [48].
Pre- and postnatal exposure has been linked with
developmental disorders in children. Prenatal residential
exposure to CPF of inner city children assessed at age 3
years was linked with impaired motor skills and
impaired mental development. Highly exposed children
are more likely to exhibit clinical symptoms of attention
problems, ADHD and pervasive developmental disorders
[20].
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agricultural production was associated with impaired
reflex functioning, particularly in those assessed after 3
days postnatal [49]. Organophosphate poisoning in chil-
dren under the age of 3 was linked with impaired verbal
learning and motor inhibition tasks, with higher impul-
sivity in OP intoxicated children [50]. Pervasive develop-
mental disorders at age 24 months were found to be
linked with uterine exposure in Mexican-American chil-
dren [51].
In mother-infant pairs exposed to indoor residential pes-
ticide exposure, a positive trend was found between mater-
nal PON1 activity and head circumference in offspring
where maternal CPF metabolite (TCPy) were above the
limit of detection [40]. Eskenazi et al (2004) [52] found an
association between increased levels of dimethyl phos-
phate metabolites (coming from malathion) in the urine in
later pregnancy and a reduced gestational duration.
Also in that study a reduced length of gestation was
f o u n di nr e l a t i o nw i t ht h ec h o linesterase levels (ChE) in
umbilical cord whole blood. Maternal dialkyl phosphate
metabolite levels and ChE levels in later pregnancy were
not correlated. Unexpectedly, there was a positive effect of
the dialkyl phosphate metabolite levels on head circumfer-
ence after correction for creatinine levels. In contrast,
Whyatt et al in 2005 [53] found a significant inverse corre-
lation between cord blood plasma CPF levels and birth
weight and length for children born before the 2001 ban.
Later follow-up of this group revealed neurodevelopmental
abnormalities at the age of 3 in relation to prenatal expo-
sure to CPF parent compound as could be expected con-
sidering the intra-uterine growth retardation [20].
Methods
The objective of this phase of the project was to identify
areas of knowledge gaps in order to prioritise issues for
further attention from scientists and policymakers. The
central focus developed for the HENVINET project was to
question which kind of policy action experts consider to
be justifiable based on the identified state of scientific
knowledge; the societal impacts and aspects were not initi-
ally addressed in depth, with the focus mainly on knowl-
edge gaps, and thus to science itself. One challenge of
such a study is the state of knowledge about health risks
caused by environmental pollution and contaminants, and
how to tease out the specific contributory effects of CPF.
The question of what to do with a large and complex
amount of data remains difficult. Measuring pollutants
and related health effects presents its own challenges, but
how should scientists interpret these results, and how
should decision-makers translate them into policy?
So within this phase of work, the scientific data were
considered specifically, with the main aim to be identifying
areas of controversy and need for further research. Further
deliberation with other stakeholders would need to occur
before specific policy recommendations could be put
forward.
One influential model of expert elicitation is given in
the RIVM Letter Report [54]. It details a process by
which uncertainties related to the question or problem
are considered, and the need to perform expert consul-
tation identified. Then three actions are applied: the
selection of experts, the identification of key uncertain-
ties for discussion, and the assembly and dissemination
of basic information.
For a more detailed explanation of HENVINET’s elicita-
tion process and the social science issues involved please
see the Keune, Gutleb et al. paper elsewhere in this
volume, “We’re only in it for the knowledge? A problem
solving turn in environment and health expert elicitation”.
Selection of experts
Subject-matter experts to assess the scientific case were
selected through identifying primary authors of published
literature in the field, as well as key and well-known
researchers in industry. A number of experts who were
approached were already in the HENVINET consortium
with a majority not involved. Most of those approached
were located in North America and Europe with a few
from Asia. About 40 experts were approached by an initial
letter detailing the aims of the project and describing the
basic information and a questionnaire, which were made
available online.
Dissemination of basic information
A literature review of the evidence regarding the contri-
bution of Chlorpyrifos (CPF) to developmental disorders
was undertaken. Details of the content of the review are
in the section Scientific Background above. Using this
review, a causal chain diagram (Fig. 1) was formulated
to be distributed to experts for their commentary and
suggestions.
The route of dissemination was through the HENVI-
NET web portal, where elements of the causal chain
diagram and the diagram in its entirety were presented
alongside the literature review. Elements of the diagram
were assessed for completeness, accuracy, and availabil-
ity of knowledge in the specified area of research.
Identification of key uncertainties
The questionnaire asked experts for their opinion of the
quality of available evidencef o rk e ya r e a so fc e r t a i n t y
about the quality of evidence in the causal chain to be
assessed on a scale of five ranging from Very High cer-
tainty to Very Low certainty.
The results of the questionnaire were tabulated in
order to identify focus areas of uncertainty and lack of
knowledge for further discussion. Using a pie chart
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nions in the area. Questions in which there was noncon-
sensus regarding certainty of the quality of knowledge
were characterised by having a spread of answers across
all possible answers. Questions in which there were dis-
agreements were characterised by answers clustering in
the ‘Very High’ and ‘Very Low’ groups with little in
between.
Figure 1 Causal chain diagram for the insecticide Chlorpyrifos This causal diagram addresses the agent chlorpyrifos (CPF) and the
evaluation of the knowledge quality used to derive the causal chain.
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First questionnaire
Of interest were areas in which there was disagreement
between experts, where the consensus regarding the
reliability of the scientific evidence could not be
achieved. Here are questions in which there was high
disagreement (Fig. 2).
There were also areas of high agreement. Experts con-
sidered the quality of evidence for a clear risk, results of
which varied from very high confidence to very low.
Many felt more research was necessary to quantify the
risk. However, when asked whether CPF should be
banned from home use, the majority agreed (Fig. 3).
None of the experts chose the ‘No, and more work
needs to be done’ or ‘No, and there is sufficient evi-
dence’ options. When asked if CPF should be banned
due to specific neurodevelopmental effects,a g a i nt h e
majority agreed (Fig. 4).
Second questionnaire and workshop
An expert consultation and second questionnaire on
policy action followed the first questionnaire. Two
respondents attended the workshop along with a social
scientist and a consortium moderator. The participants
represented the farthest ends of the continuum from the
first questionnaire. The depth of examination in such a
group can help to identify areas of concern where per-
haps a larger group would not be able to explore such
issues.
Experts agree that the three priority areas to investi-
gate are:
￿ Population behaviour, including occupation, diet,
and at-home use,
￿ Physical processes, such as uptake or absorption,
since these determine exposure, and
￿ Pathophysiological processes,l i k ee n z y m ef u n c t i o n ,
which determine exposure outcome
Figure 2 Questions regarding the level of confidence
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risks from CPF, these were identified:
￿ Population behaviour, including occupation, diet,
and at-home use,
￿ Physical processes, such as uptake or absorption,
since these determine exposure, and
￿ Pathophysiological processes,l i k ee n z y m ef u n c t i o n ,
which determine exposure outcome
Pre- and post-natal exposures were considered impor-
tant. Specific questioning for more detail revealed:
￿‘ Frequency and duration of exposure… affects health
risks’
￿‘ Age and genetic polymorphisms influence toxicity’
￿‘ More research needed… in low doses of chlorpyrifos.’
More research was recommended regarding specific
EU indoor exposures to CPF. It was also discussed
whether CPF is the causal toxin or if it is a proxy in stu-
dies for some other exposure or behaviour. Merits of
particular study designs were discussed.
It was felt both research and policy action can contri-
bute to reducing problems. One scientist commented
changes in policy were ‘feasible immediately’. More data
about exposure, better scientific understanding, and CPF
monitoring were supported.
Further comments included ‘It h i n kC P Fi sf i n ef o r
outdoor use… indoor use is of concern.’ Another sug-
gested ‘strict evaluation of current use in… domestic
settings.’
Figure 3 Level of agreement about whether CPF should be banned from home use
Figure 4 Level of agreement about if CPF should be banned due to specific neurodevelopmental effect
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A number of recommendations resulted from the previous
elicitation and the content of the conference session.
When it came to assessing the areas of most concern
to experts working in the field, population behaviour
and physical processes were considered the most impor-
tant factors in toxicological outcome.
Several areas showed important differences in terms of
expert opinion. The arguments against an indoor use ban
in the EU included the opinion that there are limited data
on effect at low, sub-toxic levels but also a request for
more epidemiological evaluation of the risk issue. Other
experts were confident that there are already enough data
to go ahead with a restriction on use. But all agreed that
because much of the epidemiological research has taken
place in North America rather than Europe and the rest of
the world, more focus and funding in the future should be
addressed on design of studies being appropriate to realis-
tic exposures in the home that are suitable to the EU.
Experts suggested more scientific research with focus on
more data and better understanding of fundamental
science – both in the cases of those opposed to and sup-
porting a restriction on CPF use. There was also a request
for policy action, especially more monitoring activities, but
also the possibility of revisiting the issue on a regular basis
in order to assess the need for some restricting and prohi-
biting activities.
Research to determine whether factors influencing use
of CPF in North America are applicable as a form of
action, to determine whether exposure at a sub-clinical
level has a measurable effect. The use of policy to decrease
or stop this exposure by raising awareness and restricting
certain activities was supported even by sceptics of CPF’s
effects on neurodevelopment.
The experts have some confidence in science coming up
with usable or decisive knowledge within the next five
years, provided research continues to be supported and
addresses the focus outlined above for EU-specific, realis-
tic-use epidemiology as well as laboratory studies.
Conclusions
As indoor usage restrictions for CPF have been considered
and rejected earlier in the EU, there are questions as to
whether policy makers could be motivated to re-examine
this topic as most participants responded that policy could
have a significant impact. Policy makers must decide
whether CPF’s negative effects are worth reconsidering
and the possibility of a ‘silent epidemic’ is something they
feel comfortable continuing to ignore.
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